Mechanisms of autoimmune liver disease

Clinics in Liver Disease

Volumn 4, Issue 2, 2000, Pages 431-445

  Mabee, Christopher L ^a   Thiele, Dwain L ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE; CHROMOSOME 6; CLINICAL FEATURE; COMPLEMENT DEPENDENT CYTOTOXICITY; HUMAN; IMMUNOPATHOGENESIS; LIVER CELL DAMAGE; LIVER INJURY; LYMPHOCYTOTOXICITY; NATURAL KILLER CELL; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0033910805     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70117-3     Document Type: Article

References (64)

1. S.J. Ackerman Eosinophils: Biologic and clinical aspects in allergy and inflammation R.R. Rich T.A. Fleischer B.D. Schwartz Clinical Immunology, Principles and Practice vol 1 1996 Mosby–Year Book St. Louis 431 448
2. A.O. Aliphantis G. Diez-Roux L.C. Mulder Do macrophages kill through apoptosis? Immunol Today 17 1996 573 576
3. M. Arenz K.H. Meyer zum Buschenfelde H.F. Lohr Limited T cell receptor V beta-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis J Hepatol 28 1998 70 77
4. F.C. Arnett The genetic basis of lupus erythematosus D. Wallace B.H. Hahn Dubois' Lupus Erythematosus ed 5 1996 Williams & Wilkins Baltimore
5. J.P. Atkinson Impact of the discovery of membrane inhibitors of complement Res Immunol 147 1996 95 100
6. E.L. Becker The cytotoxic action of neutrophils on mammalian cells in vitro Progress in Allergy 40 1988 183 208
7. J. Cianciara T. Laskus Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B Dig Dis Sci 40 1995 1842 1844
8. G.C. Cook R. Mulligan S. Sherlock Controlled prospective trial of corticosteroid therapy in acute chronic hepatitis QJM 40 1971 159
9. A.J. Czaja Autoimmune hepatitis M. Feldman B.F. Scharschmidt M.H. Sleisenger Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management ed 6 1998 WB Saunders Philadelphia 1265 1274
10. A.J. Czaja Behavior and significance of autoantibodies in type 1 autoimmune hepatitis Hepatol 30 1999 394 401
11. A.J. Czaja H.A. Carpenter Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis Gastroenterology 105 1993 1824 1835
12. Czaja AJ, Carpenter HA, Santrach PJ et al Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105:1502–1507
13. M. DeCarli M.M. D'Elios G. Zancuoghi Human Th1 and Th2 cells: Functional properties, regulation of development and role in autoimmunity Autoimmunity 18 1994 301 308
14. Donaldson PR, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701–706
15. A.L.W.F. Eddleston R. Williams Inadequate antibody response to HBsAg or suppressor T-cell defect in development of active chronic hepatitis Lancet 2 1974 1543
16. H.F. Eggink H.J. Houthoff S. Huhema Cellular and humoral immune reactions in chronic active liver disease: Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis Clin Exp Immunol 50 1982 17 24
17. L. Garcia-Buey C. Garcia-Monzon S. Rodriguez Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C Gastroenterology 108 1995 1770 1777
18. P. Garred H. Lyon P. Christoffersen Deposition ob C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis Liver 13 1993 305 310
19. M.G. Geall L.J. Schoenfield W.H.J. Summerskill Classification and treatment of chronic active liver disease Gastroenterology 63 1972 458
20. R.N. German F. Castellino R. Han Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules Immunol Rev 151 1996 5 30
21. M.J. Goldberg M.M. Kaplan T. Mitamura Evidence against an immune complex pathogenesis of primary biliary cirrhosis Gastroenterology 83 1982 677 683
22. Y.S. Hahn B. Yang T.J. Braciale Regulation of antigen processing and presentation to class I MHC restricted CD8+ T lymphocytes Immunol Rev 151 1996 31 49
23. K. Harada J. Van de Water P.S. Leung In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset Hepatology 25 1997 791 796
24. D.E. Jones J.M. Palmer O.F. James T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis Hepatology 21 1995 995 1002
25. R. Joplin J.G. Lindsay G.D. Johnson Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis Lancet 339 1992 93 94
26. M.M. Kaplan Primary biliary cirrhosis N Engl J Med 335 1996 1570 1580
27. H. Kohda C. Sekiya M. Kanai Flow cytometric and functional analysis of mononuclear cells infiltrating the liver in experimental autoimmune hepatitis Clin Exp Immunol 82 1990 473 478
28. E.L. Krawitt Autoimmune hepatitis N Engl J Med 334 1996 897 903
29. E.L. Krawitt R.J. Albertini Immunogenetics of autoimmune chronic active hepatitis K.-H. Meyer zum Buschenfelde J.H. Hoofnagle M. Manns Immunology and Liver 1993 Kluwer Academic Publishers Dordrecht, the Netherlands 240 249
30. M. Leist F. Gantner I. Bohlinger Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest J Immunol 153 1994 1778 1788
31. M. Leist F. Gantner G. Kuenstle The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure Mol Med 2 1996 109 124
32. P.S. Leung R.L. Coppel A. Ansari Antimitochondrial antibodies in primary biliary cirrhosis Semin Liver Dis 17 1997 61 69
33. X.M. Li L.J. Jeffers K.R. Reddy Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometry Hepatology 14 1991 121 127
34. C.-C. Liu L.H.Y. Young J.D.-E. Young Lymphocyte-mediated cytolysis and disease N Engl J Med 335 1996 1651 1659
35. H. Lohr B. Fleischer G. Gerken Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex J Hepatol 18 1993 322 327
36. F. Lozano A. Pares L. Borche Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis Hepatology 8 1988 930 938
37. C.L. Mabee G.R. Brown D.L. Thiele Soluble fas expression is increased in autoimmune hepatitis Hepatology 28 1998 403A
38. I.R. Mackay P.J. Morris Association of autoimmune active chronic hepatitis with HL-A1,8 Lancet 2 1972 793 795
39. Manabe K, Hibberd ML, Donaldson PT, et al. T-cell receptor constant β germline gene polymorphisms and susceptibility to autoimmune hepatitis. Gastroenterology 106:1321–1325.
40. M.P. Manns K.J. Griffen K.F. Sullivan LKM-1 autoantibodies recognize a short linear sequence in P450 IID6 J Clin Invest 88 1991 1370
41. O.M. Martinez J.C. Villanueva M.E. Gershwin Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis Hepatology 21 1995 113 119
42. Martins EB, Graham AK, Chapman RW, et al. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 23:988–993.
43. M.J. Mayo B. Combes R.N. Jenkins T-cell receptor Vbeta gene utilization in primary biliary cirrhosis Hepatology 24 1996 1148 1155
44. I.G. McFarlane The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis Gut 42 1998 599 602
45. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
46. Y. Nakanuma K. Tsuneyama N. Kono Biliary epithelial expression of pyruvate dehydrogenase complex in primary biliary cirrhosis: An immunohistochemical and immunoelectron microscopic study Hum Pathol 26 1995 92 98
47. D.R. Nelson C.G. Marousis G.L. Davis The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C J Immunol 158 1997 1473 1481
48. K.T. Nouri-Aria P.T. Donaldson J.E. Hegarty A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic hepatitis Hepatology 1 1985 235
49. Nouri-Aria KT, Hegarty JE, Alexander GJM, et al. Effect of corticosteroids on suppressor-cell activity in “autoimmune” and viral chronic active hepatitis. N Engl J Med 307:1301–1304.
50. C.J. O'Brien S. Vento P.T. Donaldson Cell-mediated immunity and suppressor T cell defects to liver-derived antigens in families of patients with autoimmune chronic hepatitis Lancet 1 1986 350
51. S. Onishi T. Saibara S. Nakata Cytotoxic activity of spleen-derived T lymphocytes against autologous biliary epithelial cells in autopsy patients with primary biliary cirrhosis Liver 13 1993 188 192
52. P. Parham NK cells, MHC class I antigens and missing self Immunol Rev 155 1997 5 221
53. B. Rehermann K.M. Chang J. McHutchison Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients J Virol 70 1996 7092 7102
54. D.A.F. Robertson S.L. Zhang E.C. Guy Persistent measles virus genome in autoimmune chronic active hepatitis Lancet 2 1987 9 11
55. M. Shindo G.E. Mullin L. Braun-Elwert Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB) Clin Exp Immunol 105 1996 254 259
56. Strettel MD, Thomson LJ, Donaldson PT, et al. HLA-C genes and susceptibility to type 1 autoimmune hepatitis. Hepatology 26:1023–1026
57. C. Szostecki H.H. Guldner H. Will Autoantibodies against “nuclear dots” in primary biliary cirrhosis Semin Liver Dis 17 1997 71 78
58. M. Tanaka T. Suda T. Yatomi Lethal effect of recombinant human fas ligand in mice pretreated with propionibacterium acnes J Immunol 158 1997 2303 2309
59. J. Van de Water A. Ansari T. Prindiville Heterogeneity of autoreactive T cell clones specific for the E2 componenet of the pyruvate dehydrogenase complex in primary biliary cirrhosis J Exp Med 181 1995 723 733
60. J. Van de Water J. Turchany P.S. Leung Molecular mimicry in primary biliary cirrhosis: Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2 J Clin Invest 91 1993 2653 2664
61. A.P. Van Den Berg Autoimmune hepatitis: Pathogenesis, diagnosis and treatment Scan J Gastroenterol 33 suppl 225 1998 66 69
62. S. Vento T. Garofano G. DiPerri Identification of hepatitis virus A as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals Lancet 337 1991 1183
63. S. Vento L. Guella F. Mirandola Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals Lancet 346 1995 608
64. M. Yachida K. Kurokohchi K. Arima Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis Clin Exp Immunol 116 1999 140 145